Literature DB >> 31642202

Proteomic Research of Molecular Defects in Globozoospermia.

Simone Ferrero1,2, Fabio Barra1,2.   

Abstract

Globozoospermia is a form of teratozoospermia characterized by round-headed spermatozoa and lack of acrosome. These spermatozoa cannot penetrate the zona pellucida of the oocyte, resulting in unsuccessful fertilization and infertility. When intracytoplasmic sperm injection is performed, the fertilization rate tends to be low. Until now, the causes of this disorder remain to be elucidated; however, mutations of some genes segregating on an autosomal recessive mode have been associated with this infertile condition. DPY19L2 (dpy-19-like 2 [Caenorhabditis elegans]) codes for a transmembrane protein expressed predominantly in spermatids, with specific localization limited to the internal nuclear membrane. Genetic defects in the DPY19L2 gene have been demonstrated the most frequent genetic cause of globozoospermia; however, intracellular molecular pathways related to its encoded protein are largely unknown. In this issue of Proteomics Clinical Applications, Guo and co-workers investigate the proteome of gloobozoospermic spermatozoa. The authors identified 491 proteins that are differentially expressed in globozoospermia (370 are upregulated and 121 are downregulated in DPY19L2-deficient globozoospermic sperm). Notably, the molecular defects identified by the authors are closely related to biological processes involved in acrosome formation, chromatin composition, sperm-egg binding, and fertilization.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  acrosome; globozoospermia; male infertility; proteomics; round-headed sperm cells

Year:  2019        PMID: 31642202     DOI: 10.1002/prca.201900111

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  1 in total

1.  Assisted reproductive treatments with hyperbaric oxygen therapy in male infertility.

Authors:  Kübra Özgök Kangal; Yaşar Özgök
Journal:  Turk J Urol       Date:  2020-10-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.